STRESS From in Charge Relative Facing the Announcement of Decisions Limiting or Stopping Treatments in Emergency Room During the COVID-19 Epidemic (COVER ACC)
Status
Conditions
Treatments
Details and patient eligibility
About
In the context of the COVID-19 pandemic, the emergency reception services had to be radically reorganized. In this tense environment, professionals must face ethical dilemmas, make referral decisions and prioritize patients. Due to the limited number of visits to many hospitals, interactions with relatives and families of patients are mainly conducted by phone. These limitations will continue as long as the context of uncertainty over the course of the pandemic persists. Limitation or discontinuation of treatment (LDT) announcements were therefore also impacted and the exceptional situation related to COVID-19 reinforces the difficulties encountered by professionals in usual time (place of announcement, inappropriate lack of time, etc.). Thus, LDTs are most often done over the phone without the families being able to go to the hospital. Because of this, these announcements can be more traumatic. Investigators have already highlighted in a recent study the lack of communication between caregivers and families in the context of LDT announcements and the context of COVID 19 exacerbated these aspects given the limitations of visits.
The investigators therefore propose to study the experiences of families who are notified of a decision to limit or stop treatment by phone in the emergency room during the COVID-19 crisis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age over 18 years old.
- Person of trust designated in writing or contact person if designated by the family or primary caregiver or failing that the family member or person of trust of an adult patient deemed unfit to receive the information (advanced dementia (lower MMS) to 10), disturbance of consciousness). Only one person per family will be included.
- having been informed of a LAT decision in the emergency room by telephone during the pandemic
- Having consented to participate in the study
- Affiliated with social security
Exclusion criteria
- Person of trust, family or close friend unable to understand or write in French.
Trial design
Primary purpose
Allocation
Interventional model
Masking
140 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Julien BERTHILLER; Marion DOUPLAT, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal